These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3381294)

  • 1. Cyclosporine therapy in chronic slowly progressive polymyositis--preliminary report of clinical results in three patients.
    Jongen PJ; Joosten EM; Berden JH; Ter Laak HJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):335-9. PubMed ID: 3381294
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine therapy in chronic inflammatory demyelinating polyradiculoneuropathy--a preliminary report of clinical results in two patients.
    Jongen PJ; Joosten EM; Berden JH; Gabreëls-Festen AA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):329-32. PubMed ID: 3381292
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine as monotherapy for polymyositis?
    Borleffs JC
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):333-4. PubMed ID: 3381293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myositis in the presence of slightly elevated creatine kinase values].
    van Vonderen MG; ter Maaten JC; van der Valk P; Hoorntje SJ; Gans RO
    Ned Tijdschr Geneeskd; 1999 May; 143(18):949-53. PubMed ID: 10368712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine in the treatment of intractable polymyositis.
    Goei The HS; Jacobs P; Houben H
    Arthritis Rheum; 1985 Dec; 28(12):1436-7. PubMed ID: 4084335
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyositis--clinical trials.
    Bunch TW
    Clin Rheum Dis; 1983 Dec; 9(3):641-53. PubMed ID: 6360518
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.
    Ludwin D; Bennett KJ; Grace EM; Buchanan WW; Bensen W; Bombardier C; Tugwell PX
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):367-70. PubMed ID: 3381299
    [No Abstract]   [Full Text] [Related]  

  • 10. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymyositis].
    Ernst K
    Z Arztl Fortbild (Jena); 1972 Jun; 66(12):612-5. PubMed ID: 4341516
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistant severe psoriasis controlled with systemic cyclosporine therapy.
    Picascia DD; Garden JM; Freinkel RK; Roenigk HH
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):58-62. PubMed ID: 3381303
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 14. Interstitial lung disease in polymyositis and dermatomyositis.
    Songcharoen S; Raju SF; Pennebaker JB
    J Rheumatol; 1980; 7(3):353-60. PubMed ID: 6967522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis.
    McKendry RJ
    Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute respiratory failure due to strongyloidiasis in polymyositis.
    McNeely DJ; Inouye T; Tam PY; Ripley SD
    J Rheumatol; 1980; 7(5):745-50. PubMed ID: 7441665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts.
    Moran M; Tomlanovich S; Myers BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):185-90. PubMed ID: 3895659
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal function in patients with autoimmune diseases treated with cyclosporine.
    von Graffenried B; Harrison WB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):215-31. PubMed ID: 3839609
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of cyclosporine on the early postoperative function of allografted kidneys with warm ischemic damage.
    Ohshima S; Fujita T; Asano H; Ono Y
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2081-4. PubMed ID: 3547911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.